Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Audentes Therapeutics
San Francisco, CA
Phone: 646-712-1001
www.audentestx.com

Audentes is a biotechnology company committed to the development and commercialization of innovative new treatments for people with serious, rare muscle diseases through the application of adeno-associated virus (AAV) gene therapy technology. The company consists of a focused, experienced and passionate team driven by the goal of improving the lives of patients. Audentes takes pride in strong, global relationships with the patient, research and medical communities.

Key Contact
Name
Matthew R. Patterson
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
07/19/13 $30,000,000 Series A 5AM Ventures
OrbiMed Advisors
Versant Ventures
undisclosed